Hormonal contraceptive use and persistent staphylococcus aureus nasal carriage

Clinical Infectious Diseases

Volumn 55, Issue 12, 2012, Pages 1625-1632

  Zanger, Philipp ^a   Nurjadi, Dennis ^a   Gaile, Marika ^a   Gabrysch, Sabine ^b   Kremsner, Peter G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN;

ADULT; ARTICLE; BACTERIAL TRANSMISSION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NASAL CARRIAGE; NOSE; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; CARRIER STATE; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GERMANY; HUMANS; MALE; MULTIVARIATE ANALYSIS; NASAL CAVITY; ODDS RATIO; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84870155582     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis778     Document Type: Article

References (53)

1. Sherertz RJ, Bassetti S, Bassetti-Wyss B. "Cloud" health-care workers. Emerg Infect Dis 2001; 7:241-4.
2. Nouwen JL, Fieren MW, Snijders S, Verbrugh HA, van Belkum A. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int 2005; 67:1084-92.
3. White A, Hemmerly T, Martin MP, Knight V. Studies on the origin of drug-resistant staphylococci in a mental hospital. Am J Med 1959; 27:26-39.
4. White A. Quantitative studies of nasal carriers of staphylococci among hospitalized patients. J Clin Invest 1961; 40:23-30.
5. Creech CB 2nd, Johnson BG, Alsentzer AR, Hohenboken M, Edwards KMTalbot TR 3rd. Vaccination as infection control: A pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage. Vaccine 2009; 28:256-60.
6. Herwaldt LA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2004; 25:481-4. (Pubitemid 38758493)
7. Peacock SJ, Justice A, Griffiths D, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003; 41:5718-25.
8. Armstrong-Esther CA. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 1976; 3:221-7.
9. Eriksen NH, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 1995; 115:51-60.
10. Olsen K, Falch BM, Danielsen K, et al. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromso Staph and Skin Study. Eur J Clin Microbiol Infect Dis 2012; 31:465-73.
11. Wang JT, Liao CH, Fang CT, et al. Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol 2009; 47:2957-63.
12. Winkler J, Block C, Leibovici L, Faktor J, Pitlik SD. Nasal carriage of Staphylococcus aureus: Correlation with hormonal status in women. J Infect Dis 1990; 162:1400-2.
13. Noble VS, Jacobson JA, Smith CB. The effect of menses and use of catamenial products on cervical carriage of Staphylococcus aureus. Am J Obstet Gynecol 1982; 144:186-9. (Pubitemid 12068875)
14. Sugarman B, Epps LR. Effect of estrogens on bacterial adherence to HeLa cells. Infect Immun 1982; 35:633-8. (Pubitemid 12164763)
15. van den Akker EL, Nouwen JL, Melles DC, et al. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 2006; 194:814-8. (Pubitemid 44344130)
16. Nouwen JL, Ott A, Kluytmans-Vandenbergh MF, et al. Predicting the Staphylococcus aureus nasal carrier state: Derivation and validation of a "culture rule". Clin Infect Dis 2004; 39:806-11.
17. Kuhl H. Pharmacology of estrogens and progestogens: Influence of different routes of administration. Climacteric 2005; 8(Suppl 1):3-63. (Pubitemid 41232429)
18. Brady A. Adjusted population attributable fractions from logistic regression. Stata Technical Bulletin Reprints 1998; 7:137-43.
19. Choi CS, Yin CS, Bakar AA, et al. Nasal carriage of Staphylococcus aureus among healthy adults. J Microbiol Immunol Infect 2006; 39:458-64.
20. Cole AM, Tahk S, Oren A, et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001; 8:1064-9. (Pubitemid 33035733)
21. Quinn GA, Cole AM. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 2007; 122:80-9. (Pubitemid 47222598)
22. Zanger P, Nurjadi D, Vath B, Kremsner PG. Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo. Infect Immun 2011; 79:2658-62.
23. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751-62.
24. Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun 2004; 72:6685-8. (Pubitemid 39425453)
25. van Belkum A, Emonts M, Wertheim H, et al. The role of human innate immune factors in nasal colonization by Staphylococcus aureus. Microbes Infect 2007; 9:1471-7. (Pubitemid 350017883)
26. Emonts M, Uitterlinden AG, Nouwen JL, et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis 2008; 197:1244-53.
27. Ruimy R, Angebault C, Djossou F, et al. Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans? J Infect Dis 2010; 202:924-34.
28. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005; 3:948-58.
29. Rooijakkers SH, van Kessel KP, van Strijp JA. Staphylococcal innate immune evasion. Trends Microbiol 2005; 13:596-601.
30. Kraus D, Peschel A. Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiol 2008; 3:437-51.
31. Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J Autoimmun 2012; 38:282-91.
32. Klein SL. The effects of hormones on sex differences in infection: From genes to behavior. Neurosci Biobehav Rev 2000; 24:627-38.
33. Styrt B, Sugarman B. Estrogens and infection. Rev Infect Dis 1991; 13:1139-50.
34. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007; 45:360-9. (Pubitemid 47101035)
35. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 2001; 185:380-5. (Pubitemid 32769440)
36. Cottingham J, Hunter D. Chlamydia trachomatis and oral contraceptive use: A quantitative review. Genitourin Med 1992; 68:209-16.
37. Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL. Genital tract shedding of herpes simplex virus type 2 in women: Effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005; 40:1422-8. (Pubitemid 40628629)
38. Smith JS, Herrero R, Munoz N, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-Age women in Brazil and the Philippines. Sex Transm Dis 2001; 28:187-94.
39. Piccoli GB, Colla L, Mezza E, Burdese M, Cammarota T, Piccoli G. Oestroprogestagens and severe acute pyelonephritis: A casual or causal association? Nephrol Dial Transplant 2006; 21:2337. (Pubitemid 44295073)
40. Simanski M, Dressel S, Gläser R, Harder J. RNase 7 protects healthy skin from Staphylococcus aureus colonization. J Invest Dermatol 2010; 130:2836-8.
41. Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus Infection of the Skin. J Infect Dis 2009; 200:1907-15.
42. Zanger P, Holzer J, Schleucher R, Scherbaum H, Schittek B, Gabrysch S. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2. Infect Immun 2010; 78:3112-7.
43. King AE, Fleming DC, Critchley HO, Kelly RW. Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol 2003; 59:1-16. (Pubitemid 36918496)
44. Han JH, Kim MS, Lee MY, et al. Modulation of human beta-defensin-2 expression by 17beta-estradiol and progesterone in vaginal epithelial cells. Cytokine 2010; 49:209-14.
45. Biswas B, Yenugu S. Antimicrobial responses in the male reproductive tract of lipopolysaccharide challenged rats. Am J Reprod Immunol 2011; 65:557-68.
46. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis 2006; 12:1638-43.
47. Dancer SJ, Noble WC. Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: Identification of strains producing epidermolytic toxin. J Clin Pathol 1991; 44:681-4.
48. Huang YC, Chao AS, Chang SD, et al. Association of Staphylococcus aureus colonization in parturient mothers and their babies. Pediatr Infect Dis J 2009; 28:742-4.
49. Beigi R, Hanrahan J. Staphylococcus aureus and MRSA colonization rates among gravidas admitted to labor and delivery: A pilot study. Infect Dis Obstet Gynecol 2007; 2007:70876.
50. Mitsuda T, Arai K, Fujita S, Yokota S. Demonstration of mother-Toinfant transmission of Staphylococcus aureus by pulsed-field gel electrophoresis. Eur J Pediatr 1996; 155:194-9.
51. Leshem E, Maayan-Metzger A, Rahav G, et al. Transmission of Staphylococcus aureus from Mothers to Newborns. Pediatr Infect Dis J 2012; 31:360-3.
52. Kazanskaia GM, Nikolaeva RV, Kovaleva VV. [Incidence of staphylococcal carriage in pregnant women]. Zh Mikrobiol Epidemiol Immunobiol 1985: 43-5.
53. Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 1999; 181(5 Pt 1):1263-9.